2021
DOI: 10.1155/2021/7389076
|View full text |Cite
|
Sign up to set email alerts
|

Hypertriglyceridemia and Other Plasma Lipid Profile Abnormalities among People Living with Diabetes Mellitus in Ethiopia: A Systematic Review and Meta-Analysis

Abstract: Background. Dyslipidemia is one of the leading causes of cardiovascular complications in diabetes mellitus (DM) patients. Though it is a major public health problem in Ethiopia, there is no a nation-wide study to determine dyslipidemia among DM patients yet. Therefore, this systematic review and meta-analysis intended to estimate the prevalence of hypertriglyceridemia and other plasma lipid abnormalities among people living with DM in Ethiopia. Methods. We systematically searched PubMed, Google Scholar, Africa… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
5
1

Year Published

2021
2021
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(8 citation statements)
references
References 64 publications
(100 reference statements)
2
5
1
Order By: Relevance
“…The pooled prevalence of elevated total cholesterol in the current review was 39.08%, comparable to studies in Iran at 41.6% [ 67 ], Poland at 37% [ 68 ], Ethiopian studies at 34.08% [ 69 ], Turkish studies at 37.50% [ 70 ], and Lebanon at 36.90% [ 71 ], but higher than China at 33% [ 72 ], Tanzania at 30.4% [ 73 ], and Korean studies at 6.00% [ 74 ]. However, studies in Saudi Arabia (54% [ 75 ]) and South Africa (67.30% [ 76 ]) found a greater prevalence of total cholesterol elevation.…”
Section: Discussionsupporting
confidence: 72%
“…The pooled prevalence of elevated total cholesterol in the current review was 39.08%, comparable to studies in Iran at 41.6% [ 67 ], Poland at 37% [ 68 ], Ethiopian studies at 34.08% [ 69 ], Turkish studies at 37.50% [ 70 ], and Lebanon at 36.90% [ 71 ], but higher than China at 33% [ 72 ], Tanzania at 30.4% [ 73 ], and Korean studies at 6.00% [ 74 ]. However, studies in Saudi Arabia (54% [ 75 ]) and South Africa (67.30% [ 76 ]) found a greater prevalence of total cholesterol elevation.…”
Section: Discussionsupporting
confidence: 72%
“…[49] Similarly, in a meta-analysis done among Ethiopians living with T2D, the prevalence of low HDL-C was reported as 44.36%, which is similar to the findings of this present meta-analysis. [50] Insulin resistance enhances the increased production of TRLs which exchange triglyceride Isezuo et al [19] 2003 Cross-sectional 40 25% NW Isezuo and Ezunu [20] 2005 Cross-sectional 254 72.4% NW Idogun et al [21] 2007 Cross-sectional 52 30% SS Okafor et al [22] 2008 Cross-sectional 192 89% SW Unadike et al [23] 2008 Cross-sectional 32 68.7% SS Ogbera et al [24] 2009 Cross-sectional 600 89% SW Kayode et al [25] 2010 Cross-sectional 113 50.4% SW Edo and Adediran [26] 2011 Cross-sectional 52 32.7% SS Jisieike-Onuigbo et al [27] 2011 Cross-sectional 108 90.7% SE Okafor et al [22] 2012 Cross-sectional 233 97.1 SE Oyelade et al [28] 2013 Cross-sectional 219 58.5% SW Edo et al [29] 2014 Retrospective 63 30.2% SS Ogedengbe and Ezeani [30] 2014 Cross-sectional 106 50.8% SE Edo and Edo [31] 2016 Retrospective 130 29.2% SS Enikuomehin et al [32] 2016 Cross-sectional 300 50.4% SW Fasanmade et al [33] 2016 Cross-sectional 218 80.7% SW Young and Onyenekwe [34] 2016 Cross-sectional 51 82.4% SE Omotoye and Fadupin [35] 2017 Cross-sectional 50 70% SW Engwa et al [36] 2018 Cross-sectional 72 40.8% SE Bello-Ovosi et al [37] 2019 Cross-sectional 322 69.3% NW Jaja and Yarhere [38] 2019 Cross-sectional 22 86.4% SS Amadi et al [39] 2020 Retrospective 346 46.8% SS NW: North-west, SS: South-south, SW: South-west, SE: South-east with cholesterol on HDL-C, making the HDL-C more susceptible to increased clearance from the bloodstream. [51] This invariably leads to low HDL-C.…”
Section: Discussionmentioning
confidence: 99%
“…The shortage of highly trained health care providers is an acute problem in Ethiopia. Today, this ultimately raises the cost of patient health care service for treating non-communicable diseases like diabetic patients and improves the standard of care Dagnew (2021).…”
Section: Statement Of the Problemmentioning
confidence: 99%